I agree something unexpected is likely to be revealed on Tuesday.
I don't see a nothingburger (looks good, continue to 390) as consistent with FDA reviewing CD12 and Seethamraju unexpectedly blurting that out.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-